Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,575.00
+15.00 (0.59%)
Last updated: Aug 29, 2025, 9:07 AM KST

Genome & Company Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
79,57985,207176,209245,897468,8271,048,465
Upgrade
Market Cap Growth
-49.97%-51.64%-28.34%-47.55%-55.28%224.28%
Upgrade
Enterprise Value
73,63789,070151,242185,907383,8411,026,945
Upgrade
Last Close Price
2560.002750.006245.008725.0017350.0039750.00
Upgrade
PS Ratio
3.313.0712.3317.461038.966962.78
Upgrade
PB Ratio
0.780.861.551.634.139.11
Upgrade
P/TBV Ratio
1.443.404.833.738.109.84
Upgrade
EV/Sales Ratio
3.073.2110.5813.20850.636819.87
Upgrade
Debt / Equity Ratio
0.350.320.230.040.060.02
Upgrade
Asset Turnover
0.200.180.090.090.000.00
Upgrade
Inventory Turnover
2.272.593.534.76--
Upgrade
Quick Ratio
2.602.803.099.838.0336.89
Upgrade
Current Ratio
2.863.083.3610.498.3237.00
Upgrade
Return on Equity (ROE)
-24.98%-25.26%-38.36%-43.15%-31.51%-80.88%
Upgrade
Return on Assets (ROA)
-9.01%-9.78%-20.55%-23.17%-17.48%-21.33%
Upgrade
Return on Capital (ROIC)
-10.31%-11.16%-23.20%-25.95%-19.03%-38.58%
Upgrade
Earnings Yield
-34.03%-23.60%-26.94%-21.08%-7.28%-2.93%
Upgrade
FCF Yield
-25.69%-23.82%-28.99%-20.50%-6.19%-1.88%
Upgrade
Buyback Yield / Dilution
-7.22%-7.88%-0.32%-4.71%-39.60%-20.11%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.